Literature DB >> 3130100

Amino acid structures of multiple forms of amyloid-related serum protein SAA from a single individual.

F E Dwulet1, D K Wallace, M D Benson.   

Abstract

Multiple forms of the acute-phase serum protein SAA were isolated from the lipoprotein fraction of plasma from a single individual. These protein forms were purified by size-exclusion, ion-exchange, and reverse-phase high-pressure liquid chromatography, and then the tryptic peptides were subjected to amino acid sequence analysis. A total of three distinct 104-residue proteins were identified. Two of these proteins differed only by having either an arginine or a histidine at position 71 while the third protein had seven amino acid differences. Each of these proteins has a 103-residue companion protein where the amino-terminal arginine has been removed. Two of these protein sequences match the two human SAA cDNA structures reported in the literature. The presence of three unique amino acid sequences in one individual is proof that there must be a minimum of two genes for SAA in humans.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3130100     DOI: 10.1021/bi00405a044

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Automated measurement of a constitutive isotype of serum amyloid A/SAA4 and comparison with other apolipoproteins.

Authors:  T Yamada; A Wada; T Yamaguchi; Y Itoh; T Kawai
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

2.  Relative serum amyloid A (SAA) values: the influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritis.

Authors:  T Yamada; Y Okuda; K Takasugi; K Itoh; J Igari
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

3.  A cell culture system for the study of amyloid pathogenesis. Amyloid formation by peritoneal macrophages cultured with recombinant serum amyloid A.

Authors:  B Kluve-Beckerman; J J Liepnieks; L Wang; M D Benson
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

4.  AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product.

Authors:  G T Westermark; K Sletten; A Grubb; P Westermark
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

5.  Human serum amyloid A protein. Complete amino acid sequence of a new variant.

Authors:  C M Beach; M C De Beer; J D Sipe; L D Loose; F C De Beer
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

6.  Human serum amyloid A. Three hepatic mRNAs and the corresponding proteins in one person.

Authors:  B Kluve-Beckerman; F E Dwulet; M D Benson
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

7.  Identification of cis-acting sequences responsible for phorbol ester induction of human serum amyloid A gene expression via a nuclear factor kappaB-like transcription factor.

Authors:  M R Edbrooke; D W Burt; J K Cheshire; P Woo
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

8.  Heterogeneity of human serum amyloid A protein. Five different variants from one individual demonstrated by cDNA sequence analysis.

Authors:  A Steinkasserer; E H Weiss; W Schwaeble; R P Linke
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

9.  Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease.

Authors:  Susan Yuditskaya; Ashaunta Tumblin; Gerard T Hoehn; Guanghui Wang; Steven K Drake; Xiuli Xu; Saixia Ying; Amy H Chi; Alan T Remaley; Rong-Fong Shen; Peter J Munson; Anthony F Suffredini; Gregory J Kato
Journal:  Blood       Date:  2008-11-20       Impact factor: 22.113

10.  Serum amyloid a truncations in type 2 diabetes mellitus.

Authors:  Hussein N Yassine; Olgica Trenchevska; Huijuan He; Chad R Borges; Dobrin Nedelkov; Wendy Mack; Naoko Kono; Juraj Koska; Peter D Reaven; Randall W Nelson
Journal:  PLoS One       Date:  2015-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.